Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5-expressing cells in Brown Norway rats

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 6, 1999, Pages 1147-1154

  Ihaku, Daizo ^a   Cameron, Lisa ^a   Suzuki, Masaru ^a   Molet, Sophie ^a   Martin, James ^a   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Antigen induced late response; Brown Norway rat; IL 5; Leukotriene; Montelukast

Indexed keywords

INTERLEUKIN 5; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MESSENGER RNA; MONTELUKAST; OVALBUMIN;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS REACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; EOSINOPHIL; HISTOPATHOLOGY; HYPEREOSINOPHILIA; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; RAT; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

EID: 0033460212     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70006-0     Document Type: Article

References (49)

1. 1. Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
2. 2. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human IL-5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-24.
3. 3. Garcia-Zepeda EA, Rothenburg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996;2:449-56.
4. 4. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989;83:1013-26.
5. 5. Powell WS, Chung D, Gravel S. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. J Immunol 1995;154:4123-32.
6. 6. Busse W. The role and contribution of leukotrienes in asthma. Ann Allergy Asthma Immunol 1998;81:17-26.
7. 4, in bronchoalveolar lavage in brochial asthma and respiratory diseases. J Allergy Clin Immunol 1989;84:19-26.
8. 4 and histamine in normal human subjects. Thorax 1984;39:500-4.
9. 4 increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982;126:449-51.
10. 10. Drazen JM, Austen KF, Lewis RA, Clark DA, Goto G, Marfat A, et al. Comparative airway and vascular activity of leukotriene C-1 and D in vivo and in vitro. Proc Natl Acad Sci USA 1980;77:4345-58.
11. 11. Nagy L, Lee TH, Goetzl EJ, Pickett WC, Kay AB. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin Exp Immunol 1982;47:541-7.
12. 12. Munoz NM, Douglas I, Mayer D, Herrnreiter A, Zhu X, Leff AR. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism. Am J Respir Crit Care Med 1997;155:1398-403.
13. 4 and granulocytic infiltration into asthmatic airways. Lancet 1993;341:989-90.
14. 14. Noonan MJ, Chervinsky P, Brandon M, Zhang J, Kundu S, McBurney J, et al. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group. Eur Respir J 1998;11:1232-9.
15. 15. Nakamura Y, Hoshino M, Sim JJ, Ishii K, Hosaka K. Sakamoto T. Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma. Thorax 1998;53:835-41.
16. 4 receptor antagonist pranlukast or an interleukin-5 monoclonal antibody. Am J Respir Crit Care Med 1996;154:850-7.
17. 17. Robinson DS, Ying S, Bentley AM, Meng Q, North J, Durham SR, et al. Relationships among numbers of bronchoalveolur lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993;92:397-403.
18. 18. Shichijo M, Ebisawa M, Miura K, Toida Y, Onda T, Saito H, et al. Relationship between histamine production from human basophils derived from atopic dermatitis donors. Int Arch Allergy Immunol 1995;107:587-91.
19. 4 production in asthma of different severities. Eur Respir J 1995;8:1465-72.
20. 20. Koshino T, Tanako S, Houjo T, Sano Y, Kudo K, Kihara H, et al. Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein mRNAs in the peripheral blood leukocytes of asthmatics. Biochem Biophys Res Commun 1998;247:510-3.
21. 21. Dandurand RJ, Wang CG, Laberge S, Martin JG, Eidelman DH. In vitro allergic bronchoconstriction in the brown norway rat. Am J Respir Crit Care Med 1994;149:1499-505.
22. 22. Varney VA, Jacobson MR, Sudderick RM, Robinson DS, Irani AMA, Schwartz LS, et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis: identification of activated T lymphocytes, eosinophils and neutrophils. Am Rev Respir Dis 1992;146;170-6.
23. 23. Eidelman DH, Minshall E, Dandurand RJ, Schotman E, Song YL, Yasruel Z, et al. Evidence for major basic protein immunoreactivity and interleukin 5 gene activation during the late phase response in explanted airways. Am J Respir Cell Mol Biol 1996;5:582-9.
24. 24. Hamid Q, Wharton J, Terenghi G, Hassall CJS, Aimi J, Taylor KM, et al. Localization of atrial natriuretic peptide mRNA and immunoreactivity in the rat heart and human atrial appendage. Proc Natl Acad Sci USA 1987;84:6760-4.
25. 25. Hamid Q, Barkans J, Meng Q, Abrams J, Kay AB, Moqbel R. Human eosinophils synthesize and secrete interleukin-6 in vitro. Blood 1996;80:1496-501.
26. 26. Watanabe A, Mishima H, Renzi PM, Xu LJ, Hamid Q, Martin JG. Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in Brown Norway rats. J Clin Invest 1995;96:1303-10.
27. 27. Hojo M, Maghni K, Issekutz TB, Martin JG. Involvement of α-4 integrins in allergic airway responses and mast cell degranulation in vivo. Am J Respir Crit Care Med 1998;158:1127-33.
28. 4 in the early and late pulmonary responses of rats to allergen challenge. Am Rev Respir Dis 1990;142:353-8.
29. 4. J Appl Physiol 1996;80:583-90.
30. 4-and antigen-induced bronchoconstriction in cynomolgus monkeys. Pulm Pharmacol 1992;5:153-7.
31. 31. Diamant Z, Grootendorst DC, Veselic-Charvat M, Timmers MC, De Smet M, Leff JA, et al. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin Exp Allergy 1999;29:42-51.
32. 4. Proc Natl Acad Sci USA. 1983;80:7626-30.
33. 33. Yu W, Xu LF, Martin JG, Powell WS. Cellular infiltration and eicosanoid synthesis in Brown Norway rat lungs after allergen challenge. Am J Respir Cell Mol Biol 1995;13:477-86.
34. 34. Lamkhioued B, Renzi PM, Abi-Younes S, Garcia-Zepeda EA, Allakhverdi Z, Ghaffar O, et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997;159:4593-601.
35. 35. Kay AB, Meng Q, Barkans J, MacFarlane A, Gilmour J, Lee TH, et al. Leukotrienes (LT) C4, D4, E4 and histamine induce eotaxin expression by human endothelial cell line and human umbilical vein endothelial cells (HUVEC) [abstract]. J Allergy Clin Immunol 1999;103.
36. 36. Ghaffar O, Hamid Q, Renzi P, Allakhverdi Z, Molet S, Hogg JC, et al. Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. Am J Respir Crit Care Med 1999;159:99.
37. 37. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schroder JM. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998;160:60-8.
38. 38. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999:103;779-88.
39. 39. Sedgwick JB, Calhoun WJ, Gleich GJ, Kita H, Abrams JS, Schwartz LB, et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Am Rev Respir Dis 1991;144:1274-81.
40. 40. Spada CS, Krauss AH, Nieves AL, Woodward DF. Effects of leukotrienes B4 (LTB4) and D4 (LTD4) on motility of isolated normodense human eosinophils and neutrophils. Adv Exp Med Biol 1997;699-706.
41. 41. Humbles AA, Conroy DM, Marleau S, Rankin SM, Palframan RT, Proudfoot AEI, et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med 1997;186:601-12.
42. 42. Wardlaw AJ, Walsh GM, Symon FA. Adhesion interactions involved in eosinophil migration through vascular endothelium. Ann NY Acad Sci 1996;796:124-37.
43. 43. Schleimer R, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 1992;148:1086-92.
44. 44. Bochner B, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995;154:799-803.
45. 45. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995;12:477-87.
46. 46. Kotsimbos TC, Ernst P, Hamid Q. Interleukin-13 and interleukin-4 are co-expressed in atopic asthma. Proc Assoc Am Phys 1996;108:368-73.
47. 47. Stankova J, Gagnon N, Rola-Pleszczynski M. Leukotriene B4 augments interleukin-2 receptor-beta (IL-2R beta) expression and IL-2R beta-mediated cytotoxic response in human peripheral blood lymphocytes. Immunology 1992;76:258-63.
48. 48. Powell WS, Xu LJ, Martin JG. Effects of dexamethasone on leukotriene synthesis and airway responses to antigen and leukotriene D4 in rats. Am J Respir Crit Care Med 1995;151:1143-50.
49. 49. Bentley AM, Hamid Q, Robinson DS, Schotman E, Meng Q, Assoufi B, et al. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells and modulation of IL-4, IL-5 and interferon gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 1996;1543:551-6.